Fluoxetine for depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Major Depressive Disorder

Why this status

  1. 13 Jul 2023: Trial registered, NCT05944926
  2. 18 Mar 2024: Trial started, NCT05944926

The trials

NCT05944926: Improving Outcomes in Depression in Primary Care in a Low Resource Setting

State
Under way
Phase
Phase 3
People
1,500 planned
Started
18 Mar 2024
Primary completion
10 Apr 2026
Arms
Antidepressant medication (fluoxetine)
Results
None posted
  1. 13 Jul 2023: Trial registered
  2. 18 Mar 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Antidepressant medication (fluoxetine), Fluoxetine 20 MG, fluoxetine (Prozac).

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.